Reproductive endocrinology

Comparison of Gonadotropin and Testosterone Therapy in Adolescent Males with Hypogonadotropic Hypogonadism

Horm Res PaediatrPublished Retrospective cohort study

Authors' conclusion

Gonadotropin therapy and TRT were both effective and safe for pubertal induction in adolescent male patients with HH. Using TRT, a steeper increase in serum testosterone levels was achieved, whereas gonadotropin therapy uniquely promoted testicular growth, emphasizing the importance of individualized treatment strategies and long-term follow-up to optimize clinical outcomes and preserve fertility potential.

Study context

Population
Male patients with hypogonadotropic hypogonadism (HH) aged <18 years, single tertiary medical center, November 2005–December 2023; evaluated at 6-month intervals for up to 36 months
Participants
70 patients
Exposure
Gonadotropin therapy vs TRT for pubertal induction
  • Gonadotropinn = 56
  • TRTn = 14reference
Outcome
Serum testosterone
Follow-up
Up to 36 months
Methodological detailssingle-centre, tertiary medical center
  • Single-centre
  • Tertiary medical center

Main finding

As reported in the abstract

GroupValueBaseline
Gonadotropin283.0 ng/dL5.2 ng/dL
TRT527.5 ng/dL5.2 ng/dL

Value

Gonadotropin283.0 ng/dL
TRT527.5 ng/dL

Baseline

Gonadotropin5.2 ng/dL
TRT5.2 ng/dL
  • TRT vs Gonadotropin: overall p < 0.05 — greater rise with TRT

Observational data: associations, not effects.

Further findings

OutcomeGonadotropin
Sperm detected on semen analysis (after pubertal induction, age ≥19 years)72.0%
Analysed25

Height SD scores

Improved significantly in both groups, without significant intergroup differences

Stretched penile length

Increased significantly in both groups

Testicular volume

Increased significantly only in the gonadotropin group

Sperm detected on semen analysis (after pubertal induction, age ≥19 years)

TRT: 2 patients underwent semen analysis, sperm detected; both received short-term gonadotropin in adulthood before testing

Original publication

Comparison of Gonadotropin and Testosterone Therapy in Adolescent Males with Hypogonadotropic Hypogonadism. Horm Res Paediatr. Published 24 December 2025. doi:10.1159/000550258

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.